- Home
- HOWL vs UAMY Comparison
HOWL vs UAMY Comparison
Compare HOWL & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- UAMY
- Stock Information
- Founded
- HOWL 2017
- UAMY 1968
- Country
- HOWL United States
- UAMY United States
- Employees
- HOWL N/A
- UAMY N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- UAMY Metal Fabrications
- Sector
- HOWL Health Care
- UAMY Industrials
- Exchange
- HOWL Nasdaq
- UAMY Nasdaq
- Market Cap
- HOWL 87.4M
- UAMY 74.2M
- IPO Year
- HOWL 2021
- UAMY N/A
- Fundamental
- Price
- HOWL $1.55
- UAMY $1.92
- Analyst Decision
- HOWL Strong Buy
- UAMY Strong Buy
- Analyst Count
- HOWL 2
- UAMY 2
- Target Price
- HOWL $13.50
- UAMY $1.75
- AVG Volume (30 Days)
- HOWL 344.3K
- UAMY 8.6M
- Earning Date
- HOWL 11-07-2024
- UAMY 11-12-2024
- Dividend Yield
- HOWL N/A
- UAMY N/A
- EPS Growth
- HOWL N/A
- UAMY N/A
- EPS
- HOWL N/A
- UAMY N/A
- Revenue
- HOWL $3,386,000.00
- UAMY $10,219,826.00
- Revenue This Year
- HOWL N/A
- UAMY N/A
- Revenue Next Year
- HOWL $34.17
- UAMY N/A
- P/E Ratio
- HOWL N/A
- UAMY N/A
- Revenue Growth
- HOWL N/A
- UAMY 28.40
- 52 Week Low
- HOWL $1.38
- UAMY $0.17
- 52 Week High
- HOWL $8.19
- UAMY $2.35
- Technical
- Relative Strength Index (RSI)
- HOWL 36.96
- UAMY 61.56
- Support Level
- HOWL $1.50
- UAMY $1.65
- Resistance Level
- HOWL $1.63
- UAMY $2.18
- Average True Range (ATR)
- HOWL 0.12
- UAMY 0.32
- MACD
- HOWL 0.00
- UAMY -0.00
- Stochastic Oscillator
- HOWL 30.09
- UAMY 59.05
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.